Loretto Motherhouse Infirmary in Nerinx, KY

Loretto Motherhouse Infirmary is a medicare and medicaid certified nursing home in Nerinx, Kentucky. It is located in Marion county at 515 Nerinx Road, Nerinx, Kentucky 40049. You can reach out to the office of Loretto Motherhouse Infirmary via phone at (270) 865-5811. This skilled nursing facility has 63 federally certified beds with average occupancy rate of 78.1%. Its legal business name is Loretto Motherhouse and has the following ownership type - Non Profit - Church Related.

Loretto Motherhouse Infirmary (Medicare CCN 185276) is certified by CMS (Centers for Medicare & Medicaid Services) and participates in both medicare and medicaid program. This means if you are part of medicare or medicaid program, you may consider this nursing facility for your medical needs. It was first certified by CMS in 1991 (33 years certified) and the last quality survey was conducted in May, 2019.

Contact Information

Loretto Motherhouse Infirmary
515 Nerinx Road, Nerinx, Kentucky 40049
(270) 865-5811


Nursing Home Profile

NameLoretto Motherhouse Infirmary
Location515 Nerinx Road, Nerinx, Kentucky
Certified ByMedicare and Medicaid
No. of Certified Beds63
Occupancy Rate78.1%
Medicare ID (CCN)185276
Legal Business NameLoretto Motherhouse
Ownership TypeNon Profit - Church Related

NPI Associated with this Nursing Home:

Nursing Homes may have multiple NPI numbers. We have found possible NPI number/s associated with Loretto Motherhouse Infirmary from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1386630028
Organization NameLORETTO MOTHERHOUSE
Address515 Nerinx Rd, Nerinx, KY 40049
Phone Number270-865-5811

News Archive

CIRM awards Cedars-Sinai $1.3M to study stem cell therapy for heart attacks

A team of Cedars-Sinai Heart Institute stem cell researchers today was awarded a $1.3 million grant from the California Institute of Regenerative Medicine to continue study of an experimental stem cell therapy that treats heart attack patients with heart-derived cells. Earlier this year, data from the first clinical trial of the stem cell treatment showed the therapy helped damaged hearts regrow healthy muscle.

Report: Rebates for those who bought their own insurance expected to average $127 per person

Millions of consumers and small businesses will receive an estimated $1.3 billion in rebates from their health plans this summer under a provision of the health care law that requires insurance companies to pay refunds if they don't spend a high enough percentage of premium dollars on health care costs, according to a study by the Kaiser Family Foundation.

Study demonstrate similarities in language acquisition between signed and spoken languages

A spoken language is more than just words and sounds. Speakers use changes in pitch and rhythm, known as prosody, to provide emphasis, show emotion, and otherwise add meaning to what they say.

AVEO receives USAN, WHO generic name approval for ficlatuzumab

AVEO Pharmaceuticals, Inc. today announced that the United States Adopted Names (USAN) Council, in consultation with the World Health Organization (WHO) International Nonproprietary Names Expert Committee, has approved the use of the nonproprietary generic name "ficlatuzumab" (pronounced fye" kla tue' zue mab) for AV-299, a potent, functional anti-HGF/c-MET antibody internally discovered at AVEO.

Read more Medical News

› Verified 3 days ago


NPI Number1427770676
Organization NameLORETTO LIVING CENTER AT LORETTO MOTHERHOUSE INC
Address515 Nerinx Rd, Nerinx, KY 40049
Phone Number270-865-5811

News Archive

CIRM awards Cedars-Sinai $1.3M to study stem cell therapy for heart attacks

A team of Cedars-Sinai Heart Institute stem cell researchers today was awarded a $1.3 million grant from the California Institute of Regenerative Medicine to continue study of an experimental stem cell therapy that treats heart attack patients with heart-derived cells. Earlier this year, data from the first clinical trial of the stem cell treatment showed the therapy helped damaged hearts regrow healthy muscle.

Report: Rebates for those who bought their own insurance expected to average $127 per person

Millions of consumers and small businesses will receive an estimated $1.3 billion in rebates from their health plans this summer under a provision of the health care law that requires insurance companies to pay refunds if they don't spend a high enough percentage of premium dollars on health care costs, according to a study by the Kaiser Family Foundation.

Study demonstrate similarities in language acquisition between signed and spoken languages

A spoken language is more than just words and sounds. Speakers use changes in pitch and rhythm, known as prosody, to provide emphasis, show emotion, and otherwise add meaning to what they say.

AVEO receives USAN, WHO generic name approval for ficlatuzumab

AVEO Pharmaceuticals, Inc. today announced that the United States Adopted Names (USAN) Council, in consultation with the World Health Organization (WHO) International Nonproprietary Names Expert Committee, has approved the use of the nonproprietary generic name "ficlatuzumab" (pronounced fye" kla tue' zue mab) for AV-299, a potent, functional anti-HGF/c-MET antibody internally discovered at AVEO.

Read more Medical News

› Verified 3 days ago

Quality Ratings:

Nursing homes vary in the quality of care and services they provide to their residents. The below quality ratings for Loretto Motherhouse Infirmary are calculated from three sources - health inspection results, staffing data, and quality measure data. This information gives you an indication of the care Loretto Motherhouse Infirmary give to their patients.
Ratings from Surveys (Inspections):
Ratings from Quality Measures:
Ratings from Staffing Data:
Overall Rating:

News Archive

CIRM awards Cedars-Sinai $1.3M to study stem cell therapy for heart attacks

A team of Cedars-Sinai Heart Institute stem cell researchers today was awarded a $1.3 million grant from the California Institute of Regenerative Medicine to continue study of an experimental stem cell therapy that treats heart attack patients with heart-derived cells. Earlier this year, data from the first clinical trial of the stem cell treatment showed the therapy helped damaged hearts regrow healthy muscle.

Report: Rebates for those who bought their own insurance expected to average $127 per person

Millions of consumers and small businesses will receive an estimated $1.3 billion in rebates from their health plans this summer under a provision of the health care law that requires insurance companies to pay refunds if they don't spend a high enough percentage of premium dollars on health care costs, according to a study by the Kaiser Family Foundation.

Study demonstrate similarities in language acquisition between signed and spoken languages

A spoken language is more than just words and sounds. Speakers use changes in pitch and rhythm, known as prosody, to provide emphasis, show emotion, and otherwise add meaning to what they say.

AVEO receives USAN, WHO generic name approval for ficlatuzumab

AVEO Pharmaceuticals, Inc. today announced that the United States Adopted Names (USAN) Council, in consultation with the World Health Organization (WHO) International Nonproprietary Names Expert Committee, has approved the use of the nonproprietary generic name "ficlatuzumab" (pronounced fye" kla tue' zue mab) for AV-299, a potent, functional anti-HGF/c-MET antibody internally discovered at AVEO.

Read more Medical News

› Verified 3 days ago

Complaints, Fines and Penalties:

Number of Facility Reported Incidents0
Number of Substantiated Complaints0
Number of Fines0
Total Amount of Fines in Dollars$0
Number of Payment Denials0
Total Number of Penalties0

Patients' Stay Experience:

The resident survey data of Loretto Motherhouse Infirmary is compared against the national average with the color code indicators: Better than National Average Worse than National Average

Experience MeasureProviderNational Avg.
Percentage of long-stay residents whose need for help with daily activities has increased25.714.46
Percentage of long-stay residents who lose too much weight3.175.51
Percentage of low risk long-stay residents who lose control of their bowels or bladder60.7148.41
Percentage of long-stay residents with a catheter inserted and left in their bladder1.571.79
Percentage of long-stay residents with a urinary tract infection3.112.65
Percentage of long-stay residents who have depressive symptoms1.65.05
Percentage of long-stay residents who were physically restrained00.23
Percentage of long-stay residents experiencing one or more falls with major injury10.773.36
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine99.4993.87
Percentage of long-stay residents who received an antipsychotic medication20.8314.2
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine10083.88